By
Health leaders, professionals and activists
Published: July 24, 2015, 8:26 p.m.·
Tags:
Access,
Advocacy
Stocks of medicines for drug-resistant tuberculosis are insufficient, and further shortages – leading to more tuberculosis and more drug resistance – are expected.
Read More →
By
Stop TB Partnership
Published: July 24, 2015, 8:11 p.m.·
Tags:
Global TB response
The European region has special challenges to face: high MDR and XDR-TB rates, lengthy hospital stays, and the need for changes in health, human rights policies including decriminalization, real civil society and community engagement.
Read More →
By
Joint TB Monitoring Mission
Published: July 23, 2015, 8:25 p.m.·
Tags:
TB programs
Central TB Division (CTD) organised the Joint Monitoring Mission (JMM) in April 2015 along with the World Health Organisation country office to review the functioning of the Revised National TB Control Programme (RNTCP) of India.
Read More →
By
TB CAB,
Treatment Action Group
Published: July 23, 2015, 5:23 p.m.·
Tags:
Research and development,
Access,
Advocacy,
TB CAB
The TB CAB and TAG restate their request to Johns Hopkins University to allow representatives of TB-affected communities to comment on the terms of any agreement with Sequella before it is finalized.
Read More →
By
Médecins Sans Frontières
Published: July 21, 2015, 5:13 p.m.·
Tags:
HIV coinfection
New MSF report surveying lay counsellor policies across eight countries highlights major weaknesses for adherence support.
Read More →
By
Stop TB Partnership
Published: July 18, 2015, 4:41 p.m.·
Tags:
Global TB response,
Advocacy
Despite the critical need for increased TB resources, donor funding for TB decreased by nearly 10% in 2014.
Read More →
By
HIV i-Base,
Treatment Action Group
Published: July 18, 2015, 1:32 p.m.·
Tags:
Medicines,
Vaccines,
Diagnostics,
Prevention,
Scientific research,
HIV coinfection,
Hepatitis C
Latest annual review on HIV, HCV and TB drugs, diagnostics, vaccines, preventive technologies, research toward a cure, and immune-based and gene therapies in development.
Read More →
By
Otsuka Pharmaceutical Co., Ltd.
Published: July 16, 2015, 8:56 p.m.·
Tags:
Drug-resistant TB,
Treatment
Analysis of data from Phase IIb trial showed that delamanid plus a background regimen may be a promising treatment option in complex, difficult-to-treat XDR-TB patients.i
Read More →
By
UNAIDS
Published: July 14, 2015, 7:59 p.m.·
Tags:
Global TB response,
HIV coinfection
Tuberculosis remains a leading cause of death among people living with HIV, accounting for one in five AIDS-related deaths globally. However, between 2004 and 2014, TB deaths declined by 33% thanks to the rapid increase in antiretroviral treatment, which reduces the risk that a person living with HIV will develop TB by 65%.
Read More →
By
International Union Against Tuberculosis and Lung Disease
Published: July 8, 2015, 11:04 p.m.·
Tags:
Events
Registration is now open for the 46th Union World Conference on Lung Health in Cape Town. An early-bird discount is offered through 1 September 2015.
Read More →
Page 74 of 131 · Total posts: 10
←First
73
74
75
Last→